PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $690,000 | +99.4% | 13,744 | +59.4% | 0.04% | +156.2% |
| Q2 2022 | $346,000 | +7.5% | 8,625 | 0.0% | 0.02% | +23.1% |
| Q1 2022 | $322,000 | -13.9% | 8,625 | -8.1% | 0.01% | 0.0% |
| Q4 2021 | $374,000 | -23.5% | 9,388 | -28.5% | 0.01% | -13.3% |
| Q3 2021 | $489,000 | -22.9% | 13,131 | -12.4% | 0.02% | 0.0% |
| Q2 2021 | $634,000 | -10.7% | 14,989 | 0.0% | 0.02% | -11.8% |
| Q1 2021 | $710,000 | -35.6% | 14,989 | -17.0% | 0.02% | -26.1% |
| Q4 2020 | $1,102,000 | +21.5% | 18,063 | -6.9% | 0.02% | +15.0% |
| Q3 2020 | $907,000 | -13.7% | 19,411 | -6.3% | 0.02% | -13.0% |
| Q2 2020 | $1,051,000 | -12.7% | 20,712 | -23.3% | 0.02% | -20.7% |
| Q1 2020 | $1,204,000 | -5.0% | 26,995 | +2.4% | 0.03% | +3.6% |
| Q4 2019 | $1,267,000 | +111.5% | 26,375 | +48.9% | 0.03% | +100.0% |
| Q3 2019 | $599,000 | -32.2% | 17,717 | -9.7% | 0.01% | -30.0% |
| Q2 2019 | $883,000 | +99.8% | 19,617 | +67.1% | 0.02% | +100.0% |
| Q1 2019 | $442,000 | +9.7% | 11,741 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $403,000 | – | 11,741 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |